Oleolive nabs $2.5M from the NIA to Develop Drug that Modulates Neurometabolism in Alzheimer's Disease
Oleolive, partnered with Auburn University, is targeting insulin sensitivity and neuroinflammation in its quest to treat Alzheimers Disease
United States Virgin Olive Oil National Cancer Institute Rajesh Amin At Auburn University Small Business Innovation Research Department Of Defense
Source: einnews.com